Anti-TLR2 Therapy Limits α-Synuclein Spread in Models
In an exciting development that promises to reshape our understanding of neurodegenerative disease mechanisms, researchers have unveiled a novel immunotherapeutic approach targeting TLR2 (Toll-like receptor...
















